Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Arrowhead Pharmaceuticals, Inc.

http://arrowheadpharma.com/

Latest From Arrowhead Pharmaceuticals, Inc.

Novartis Plumps For Share Buybacks Before Bolt-On M&A

The Basel-headquartered giant has decided to spend a major chunk of its $20.7bn windfall from the sale of its stake in Roche on a stock repurchasing program up to the end of 2023, disappointing some observers who wanted to see big licensing deals or acquisitions.

Business Strategies M & A

Pfizer And Ionis’s Antisense Cholesterol Candidate Sparks Safety Worries

Increases in liver enzymes and fat could dampen approval prospects despite vupanorsen meeting its mid-stage primary endpoint, some analysts have said.

Clinical Trials Cardiovascular

Arrowhead Gets $120m From GSK For First-In-Class NASH RNAi Candidate

GSK enters the NASH race with a mid-stage candidate while Arrowhead gets to focus its R&D spending on candidates it may bring to market itself.

Deals Business Strategies

RNAi Returns To Spotlight As Novo Nordisk Swoops For Dicerna

The Denmark-headquartered major is impressed with what it has seen in Dicerna in the two years since the companies teamed up and is paying an 80% premium to get hold of the US firm's RNAi technology platforms.

M & A Business Strategies
See All

Company Information

  • Industry
  • Pharmaceuticals
  • Pharmaceuticals
    • Drug Delivery
      • Macromolecule
      • Site Specific
  • Biotechnology
    • Antisense, Oligonucleotides
    • Gene Therapy, Cell Therapy
    • Large Molecule
    • Nanotechnology, Chips, etc.
  • Other Names / Subsidiaries
    • Ablaris Therapeutics, Inc.
    • Alvos Therapeutics, Inc. (formerly Mercator Therapeutics, Inc.)
    • Arrowhead Research Corporation
    • Calando Pharmaceuticals, Inc.
    • Unidym
UsernamePublicRestriction

Register